GO:0071002 U4atac/U6atac snRNP: Components, Assembly and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0071002 describes the U4atac/U6atac snRNP, a small nuclear ribonucleoprotein complex built from the base-paired U4atac and U6atac snRNAs, an Sm heptamer on U4atac, and an Lsm2-8 heptamer on U6atac.
• This complex is a dedicated subunit of the minor (U12-type) spliceosome, which removes a rare class of introns from a subset of human genes.
• The protein composition of the U4atac/U6atac.U5 tri-snRNP closely parallels that of the major U4/U6.U5 tri-snRNP, indicating shared assembly logic.
• U6atac snRNA is highly unstable and acts as a regulated molecular switch that controls minor-intron splicing output.
• Mutations in U4atac snRNA cause MOPD I (Taybi-Linder syndrome), a severe developmental disorder linked to defective minor spliceosome function.
• Studying GO:0071002 requires combining structural biology, RNA-protein biochemistry, and CRISPR-based cell models to dissect assembly and function.
Description
The U4atac/U6atac snRNP (GO:0071002) is a ribonucleoprotein complex that contains the extensively base-paired small nuclear RNAs U4atac and U6atac, a heptameric ring of Sm proteins associated with U4atac, the Lsm2-8 heptameric ring complex associated with U6atac, and additional proteins unique to these snRNPs. It is a core building block of the minor spliceosome, the machinery that excises U12-type introns from a small but essential fraction of human genes. Because minor introns are enriched in genes controlling DNA replication, cell cycle, and development, the U4atac/U6atac snRNP sits at a regulatory nexus for cell proliferation and differentiation. Researchers care about GO:0071002 for several reasons. First, its assembly and recycling are mechanistically distinct from the canonical U4/U6 snRNP, even though the two complexes share many proteins. Second, the abundance of U6atac snRNA is limiting and tightly controlled, making this complex a sensitive node for splicing regulation. Third, mutations in U4atac snRNA cause MOPD I, a developmental disorder that has become a paradigm for minor spliceosome disease. Finally, recent cryo-EM structures of the fully assembled human minor spliceosome have revealed how U4atac/U6atac engages U12-type introns, opening new avenues for targeted perturbation. This article summarizes the QuickGO definition, the structure and composition of the complex, its molecular mechanism, the genes and proteins involved, disease links, and the experimental methods, including CRISPR-based models, that are used to study GO:0071002.
U4atac/U6atac snRNP At A Glance
| GO ID | GO:0071002 |
|---|---|
| GO term | U4atac/U6atac snRNP |
| Ontology | cellular_component |
| Synonym | None listed in QuickGO |
| Major function | Core subunit of the minor (U12-type) spliceosome; delivers U6atac to the catalytic center for U12-type intron removal |
| RNA components | U4atac snRNA and U6atac snRNA, extensively base-paired |
| Protein rings | Sm heptamer on U4atac; Lsm2-8 heptamer on U6atac |
| Associated complexes | U4atac/U6atac.U5 tri-snRNP and downstream minor spliceosomal complexes |
| Disease relevance | Mutations in U4atac snRNA cause MOPD I (Taybi-Linder syndrome) |
What Is GO:0071002?
In the QuickGO definition, GO:0071002 is a cellular component: a ribonucleoprotein complex that contains the extensively base paired small nuclear RNAs U4atac and U6atac, a heptameric ring of Sm proteins associated with U4atac, the Lsm2-8 heptameric ring complex associated with U6atac, as well as several proteins that are unique to the U4atac snRNP or U6atac snRNPs, some of which remain associated with the U4atac/U6atac snRNA both while the U4atac snRNP is free or assembled into a series of spliceosomal complexes.
Why Is U4atac/U6atac snRNP Important in Cell Biology?
GO:0071002 is important because it defines the RNA-protein machine that enables minor-class intron splicing, a process required for the expression of hundreds of human genes involved in proliferation, DNA repair, and development. Unlike the canonical major spliceosome, the minor spliceosome relies on a distinct set of snRNAs, including U4atac and U6atac, and its function is rate-limited by the availability of U6atac snRNA. Consequently, the U4atac/U6atac snRNP is a regulatory hub whose perturbation alters cell cycle progression and differentiation. Its clinical relevance is underscored by MOPD I, where U4atac mutations impair minor spliceosome activity and cause severe developmental defects. Understanding this complex therefore informs both basic splicing biology and disease mechanisms.
• Defines the RNA-protein core of the minor spliceosome, which removes U12-type introns from a subset of human genes.
• Provides a distinct assembly paradigm compared with the major U4/U6 snRNP, despite shared protein composition.
• U6atac snRNA is highly unstable, making this complex a regulated molecular switch for minor-intron splicing.
• Mutations in U4atac snRNA cause MOPD I, linking GO:0071002 to human developmental disease.
• Minor introns are enriched in cell cycle, DNA replication, and DNA repair genes, so this complex influences genome maintenance.
• Recycling of the U12-type spliceosome requires p110, a U6atac snRNP component, highlighting dedicated factors.
• The abundance of spliceosomal snRNPs, including minor ones, is not the sole limiting factor for splicing, revealing additional regulation.
• Lsm proteins, including LSM7, coordinate snRNA modification and spliceosome fidelity, connecting GO:0071002 to RNA modification pathways.
• Structural studies of the fully assembled human minor spliceosome provide a framework for targeting U4atac/U6atac interactions.
• CRISPR-based models enable causal testing of genes encoding U4atac/U6atac snRNP components.
What Happens During U4atac/U6atac snRNP?
Assembly of the U4atac/U6atac snRNP
In simple terms: The two snRNAs and their protein rings come together to form a single particle.
The U4atac/U6atac snRNP is assembled when U4atac snRNA, bound by the Sm heptamer, base-pairs extensively with U6atac snRNA, which carries the Lsm2-8 heptamer. Additional proteins unique to these snRNPs associate with the complex and remain bound while U4atac snRNP is free or incorporated into spliceosomal complexes. The resulting particle is a stable ribonucleoprotein unit that can be recruited to the minor spliceosome.
Integration into the U4atac/U6atac.U5 tri-snRNP
In simple terms: The U4atac/U6atac particle joins another particle called U5 to form a tri-snRNP.
The U4atac/U6atac snRNP associates with the U5 snRNP to form the U4atac/U6atac.U5 tri-snRNP, which is a key intermediate in minor spliceosome assembly. Biochemical characterization has shown that the human U4/U6.U5 and U4atac/U6atac.U5 tri-snRNPs exhibit similar protein compositions, indicating that the minor tri-snRNP uses a largely shared set of protein factors. This tri-snRNP is then recruited to the U12-type intron-containing pre-mRNA.
Engagement of U12-type introns by the minor spliceosome
In simple terms: The tri-snRNP docks onto the intron and helps catalyze its removal.
Cryo-EM structures of the fully assembled human minor spliceosome have revealed how the U4atac/U6atac snRNP engages U12-type introns within the catalytic core. During this process, U6atac snRNA is positioned to participate in catalysis, while U4atac is displaced or rearranged to allow the active conformation. This structural transition is essential for the two-step transesterification reactions that excise the intron.
Recycling of the U12-type spliceosome
In simple terms: After splicing, the machine is taken apart and reused.
Recycling of the U12-type spliceosome requires p110, a component of the U6atac snRNP, which is necessary for the disassembly and reuse of spliceosomal components. This recycling step ensures that limiting factors such as U6atac snRNA can be reutilized for subsequent rounds of splicing. Defects in recycling can therefore reduce the efficiency of minor-intron splicing.
Regulation by U6atac snRNA stability
In simple terms: The amount of one snRNA controls how much splicing can happen.
Minor introns behave as embedded molecular switches that are regulated by the highly unstable U6atac snRNA. Because U6atac snRNA is rapidly turned over, its availability limits the assembly of the U4atac/U6atac snRNP and thus the rate of minor-intron splicing. This regulatory feature allows cells to modulate the expression of minor-intron-containing genes in response to physiological signals.
Key Genes Involved in GO:0071002 U4atac/U6atac snRNP
The following genes and proteins are core components or dedicated factors of the U4atac/U6atac snRNP (GO:0071002) and its associated minor spliceosome.
| Gene | Major Role | Research Relevance |
|---|---|---|
| U4atac | snRNA component base-paired with U6atac; carries Sm ring | Mutations cause MOPD I; domains required for U12-dependent splicing |
| U6atac | snRNA component base-paired with U4atac; carries Lsm2-8 ring | Highly unstable; rate-limiting for minor-intron splicing |
| LSM2 | Lsm2-8 heptamer subunit on U6atac | Core component of U6atac snRNP; required for complex stability |
| LSM3 | Lsm2-8 heptamer subunit on U6atac | Core component; part of the U6atac ring |
| LSM4 | Lsm2-8 heptamer subunit on U6atac | Core component; part of the U6atac ring |
| LSM5 | Lsm2-8 heptamer subunit on U6atac | Core component; part of the U6atac ring |
| LSM6 | Lsm2-8 heptamer subunit on U6atac | Core component; part of the U6atac ring |
| LSM7 | Lsm2-8 heptamer subunit on U6atac | Coordinates scaRNA-mediated snRNA modification and spliceosome fidelity |
| LSM8 | Lsm2-8 heptamer subunit on U6atac | Core component; part of the U6atac ring |
| SNRPB | Sm heptamer subunit on U4atac | Core component of U4atac snRNP |
| SNRPD1 | Sm heptamer subunit on U4atac | Core component of U4atac snRNP |
| SNRPD2 | Sm heptamer subunit on U4atac | Core component of U4atac snRNP |
| SNRPD3 | Sm heptamer subunit on U4atac | Core component of U4atac snRNP |
| SNRPE | Sm heptamer subunit on U4atac | Core component of U4atac snRNP |
| SNRPF | Sm heptamer subunit on U4atac | Core component of U4atac snRNP |
| SNRPG | Sm heptamer subunit on U4atac | Core component of U4atac snRNP |
| p110 | U6atac snRNP component required for spliceosome recycling | Dedicated factor for U12-type spliceosome disassembly |
| U5 snRNP proteins | Shared with U4atac/U6atac.U5 tri-snRNP | Tri-snRNP assembly and recruitment |
How Is U4atac/U6atac snRNP Regulated?
The U4atac/U6atac snRNP is regulated at multiple levels. The most prominent is the stability of U6atac snRNA, which is highly unstable and acts as a limiting factor for minor-intron splicing; changes in its turnover directly alter the amount of functional U4atac/U6atac snRNP. In addition, the abundance of spliceosomal snRNPs is not by itself limiting for splicing, indicating that additional regulatory layers control the efficiency of U12-type intron removal. LSM7, a component of the Lsm2-8 ring, coordinates scaRNA-mediated snRNA modification to ensure spliceosome fidelity, linking RNA modification pathways to the regulation of this complex. Recycling of the U12-type spliceosome by p110 also provides a post-splicing regulatory step that affects the availability of U6atac snRNP for subsequent rounds.
U4atac/U6atac snRNP and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| U4atac | MOPD I (Taybi-Linder syndrome); defective minor spliceosome function | Patient-derived fibroblasts; knock-in of patient mutations in cell lines |
| U6atac | Regulated molecular switch for minor-intron splicing; instability affects splicing output | Overexpression and knockdown cell models; stability reporters |
| LSM7 | Spliceosome fidelity and spermatogonial stem cell differentiation | Knockout in stem cell models; differentiation assays |
| p110 | U12-type spliceosome recycling defects | Knockout or knockdown in HEK293 cells; splicing assays |
| U5 snRNP proteins | Tri-snRNP assembly and minor spliceosome function | Tagged knock-in for proteomics; assembly assays |
MOPD I (Taybi-Linder syndrome) and U4atac mutations
Mutations in the U4atac snRNA gene cause MOPD I (microcephalic osteodysplastic primordial dwarfism type I, also known as Taybi-Linder syndrome), a severe developmental disorder. Biochemical studies of patient-derived cells have revealed defects in minor spliceosome function, including impaired U12-type intron splicing, providing a direct link between GO:0071002 and disease. The U4atac snRNA domains required for U12-dependent splicing in vivo have been mapped, helping to explain how specific mutations disrupt the complex.
Minor spliceosome dysfunction in developmental disorders
Because minor introns are enriched in genes controlling cell cycle and development, impaired U4atac/U6atac snRNP function can lead to broad developmental consequences. The highly unstable nature of U6atac snRNA makes the complex sensitive to perturbations that affect RNA stability or modification. LSM7, which coordinates snRNA modification, is required for spliceosome fidelity and for spermatogonial stem cell differentiation, suggesting that Lsm2-8 ring dysfunction can affect tissue-specific differentiation programs.
Cancer and cell cycle control
Minor introns are embedded molecular switches in genes that regulate proliferation and the cell cycle, so altered U4atac/U6atac snRNP activity could influence cancer-related pathways. The abundance of spliceosomal snRNPs, including minor ones, is not the sole determinant of splicing, implying that cancer cells may exploit regulatory steps such as U6atac stability. Targeting the minor spliceosome, including the U4atac/U6atac snRNP, is therefore an area of active investigation for splicing-directed therapies.
From U4atac/U6atac snRNP-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is a candidate gene required for U4atac/U6atac snRNP assembly? | CRISPR knockout in HEK293 or HeLa cells followed by snRNA analysis |
| Does a specific U4atac mutation impair U12-type splicing? | Point-mutation knock-in of the patient variant in a cell line |
| Where does a protein localize within the complex? | Tagged knock-in (e.g., GFP or FLAG) for imaging and proteomics |
| Does overexpression of U6atac alter minor-intron splicing? | Overexpression cell models with splicing reporters |
| What is the role of LSM7 in snRNA modification? | Knockout or point-mutation models in stem cells |
| Can we rescue recycling defects by restoring p110? | Knock-in or overexpression rescue in knockout background |
How to Study the U4atac/U6atac snRNP Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Cryo-EM | 3D structure of the minor spliceosome | Mapping U4atac/U6atac interactions and disease mutations |
| Mass spectrometry | Protein composition of tri-snRNPs | Comparing U4/U6.U5 and U4atac/U6atac.U5 complexes |
| RNA-seq | Global minor-intron splicing efficiency | Assessing effects of factor depletion |
| In vitro splicing assay | U12-type intron removal activity | Testing U4atac domains and mutations |
| CRISPR knockout | Loss-of-function phenotype | Testing requirement of candidate genes |
| CRISPR knock-in | Effect of specific mutations or tags | Modeling MOPD I mutations; imaging |
| Overexpression | Gain-of-function or rescue | Modulating U6atac levels |
| Proteomics of tagged complexes | Associated proteins and dynamics | Identifying unique U4atac/U6atac factors |
Structural biology (cryo-EM)
Cryo-electron microscopy of the fully assembled human minor spliceosome has provided near-atomic resolution views of how the U4atac/U6atac snRNP engages U12-type introns. These structures reveal the arrangement of the Sm and Lsm rings, the base-pairing between U4atac and U6atac, and the conformational changes required for catalysis. Structural studies are essential for mapping disease mutations onto the complex.
RNA-protein biochemistry and proteomics
Biochemical purification of U4atac/U6atac.U5 tri-snRNPs followed by mass spectrometry has shown that the minor and major tri-snRNPs have similar protein compositions. Affinity purification of tagged components can identify unique proteins that remain associated with the complex throughout spliceosomal assembly. These approaches define the molecular inventory of GO:0071002.
Splicing assays and RNA-seq
In vitro and in vivo splicing assays using U12-type intron reporters can measure the functional impact of perturbations in U4atac/U6atac snRNP components. RNA-seq of cells depleted of specific factors reveals global changes in minor-intron splicing efficiency. Such assays are used to test whether candidate genes are required for minor spliceosome function.
CRISPR-based perturbation and imaging
CRISPR knockout, point-mutation knock-in, and tagged knock-in models allow causal testing of genes encoding U4atac/U6atac snRNP components. Fluorescence imaging of tagged snRNP proteins or snRNAs can track assembly and localization in living cells. These models complement biochemical and structural approaches.
How CRISPR Can Be Used to Study GO:0071002 U4atac/U6atac snRNP
Knockout
CRISPR knockout of genes encoding U4atac/U6atac snRNP components, such as LSM7 or p110, can reveal their requirement for minor spliceosome assembly and function. Knockout cell lines are used to measure changes in U12-type intron splicing by RNA-seq and to assess proliferation or differentiation phenotypes. These models provide causal evidence for gene function in GO:0071002.
Point Mutation
Point-mutation knock-in can model disease-associated variants, such as those in U4atac snRNA that cause MOPD I. By introducing the exact patient mutation into a cell line, researchers can measure its effect on U4atac/U6atac snRNP assembly and splicing activity. This approach is valuable for dissecting structure-function relationships within the complex.
Knock-in
Tagged knock-in of U4atac/U6atac snRNP proteins (e.g., GFP or FLAG) enables imaging and affinity purification of the complex from cells. Knock-in of reporter constructs containing U12-type introns allows real-time monitoring of minor spliceosome activity. These models are essential for studying assembly dynamics and protein interactions.
Overexpression
Overexpression of U6atac snRNA or specific U4atac/U6atac snRNP proteins can test whether increased levels enhance or disrupt minor-intron splicing. Because U6atac is highly unstable and rate-limiting, overexpression models are particularly informative for regulation. Overexpression can also be used for rescue experiments in knockout backgrounds.
How EDITGENE Supports U4atac/U6atac snRNP Research
Researchers studying U4atac/U6atac snRNP-related genes often need to determine whether a candidate gene is causally involved in minor spliceosome assembly, splicing fidelity, or disease. EDITGENE provides the full suite of CRISPR cell model services to enable these experiments, from knockout to precise point mutations and tagged knock-ins.
Contact EDITGENE today to design your custom CRISPR model for U4atac/U6atac snRNP research.
Frequently Asked Questions About U4atac/U6atac snRNP
What is the U4atac/U6atac snRNP (GO:0071002)?
It is a ribonucleoprotein complex containing base-paired U4atac and U6atac snRNAs, an Sm ring on U4atac, and an Lsm2-8 ring on U6atac, serving as a core subunit of the minor spliceosome.
What genes are involved in the U4atac/U6atac snRNP?
Key genes include U4atac, U6atac, LSM2-8, SNRPB, SNRPD1-3, SNRPE, SNRPF, SNRPG, and p110.
What does the U4atac/U6atac snRNP do?
It delivers U6atac snRNA to the minor spliceosome catalytic core to remove U12-type introns from pre-mRNA.
How is the U4atac/U6atac snRNP assembled?
U4atac and U6atac snRNAs base-pair, each bound by their respective Sm or Lsm rings, and associate with unique proteins before joining U5 to form the tri-snRNP.
What diseases are linked to U4atac/U6atac snRNP mutations?
Mutations in U4atac snRNA cause MOPD I (Taybi-Linder syndrome), a severe developmental disorder with defective minor spliceosome function.
Why is U6atac snRNA important for splicing regulation?
U6atac snRNA is highly unstable and acts as a limiting molecular switch that controls minor-intron splicing output.
How can CRISPR be used to study the U4atac/U6atac snRNP?
CRISPR knockout, point-mutation knock-in, and tagged knock-in can test gene function, model disease mutations, and visualize the complex.
What methods are used to study GO:0071002?
Cryo-EM, mass spectrometry, RNA-seq, in vitro splicing assays, and CRISPR-based perturbation are commonly used.
Is the U4atac/U6atac snRNP the same as the U4/U6 snRNP?
No, it is the minor spliceosome counterpart, containing U4atac and U6atac instead of U4 and U6, though protein compositions are similar.
What is the role of LSM7 in the U4atac/U6atac snRNP?
LSM7 is part of the Lsm2-8 ring and coordinates scaRNA-mediated snRNA modification to ensure spliceosome fidelity.
Conclusion
The U4atac/U6atac snRNP (GO:0071002) is a specialized ribonucleoprotein complex that powers minor-class intron splicing and is essential for the expression of a subset of human genes. Its assembly, regulation by U6atac stability, and recycling by p110 are critical for splicing fidelity, and its dysfunction is directly linked to MOPD I and potentially other developmental disorders. Continued research using structural biology, proteomics, and CRISPR-based cell models will further illuminate how this complex operates and how it can be targeted therapeutically.
References
- 1. Bai R et al.. 2024. Structural basis of U12-type intron engagement by the fully assembled human minor spliceosome.. Science 383(6688):1245-1252 PMID: 38484052
- 2. Schneider C et al.. 2002. Human U4/U6.U5 and U4atac/U6atac.U5 tri-snRNPs exhibit similar protein compositions.. Mol Cell Biol 22(10):3219-29 PMID: 11971955
- 3. Damianov A et al.. 2004. Recycling of the U12-type spliceosome requires p110, a component of the U6atac snRNP.. Mol Cell Biol 24(4):1700-8 PMID: 14749385
- 4. Pessa HK et al.. 2006. The abundance of the spliceosomal snRNPs is not limiting the splicing of U12-type introns.. RNA 12(10):1883-92 PMID: 16957280
- 5. Qi H et al.. 2026. LSM7 coordinates scaRNA-mediated snRNA modification to ensure spliceosome fidelity and spermatogonial stem cell differentiation.. Cell Death Differ PMID: 42168358
- 6. Shukla GC et al.. 2002. Domains of human U4atac snRNA required for U12-dependent splicing in vivo.. Nucleic Acids Res 30(21):4650-7 PMID: 12409455
- 7. Jafarifar F et al.. 2014. Biochemical defects in minor spliceosome function in the developmental disorder MOPD I.. RNA 20(7):1078-89 PMID: 24865609
- 8. Younis I et al.. 2013. Minor introns are embedded molecular switches regulated by highly unstable U6atac snRNA.. Elife 2:e00780 PMID: 23908766
